Skin tests with SARS-CoV2 vaccine excipients in patients with first-dose
mucous-cutaneous adverse reactions: a purpose of allergologic workup
- Leonardo Bianchi
, - Filippo Biondi,
- Katharina Hansel,
- Nicola Murgia,
- Alessandro D’Arpino,
- Marta Tramontana,
- Luca Stingeni
Filippo Biondi
Section of Dermatology Department of Medicine and Surgery University of Perugia Italy
Author ProfileKatharina Hansel
Section of Dermatology Department of Medicine and Surgery University of Perugia Italy
Author ProfileNicola Murgia
Section of Occupational Medicine Respiratory Diseases and Toxicology Department of Medicine and Surgery University of Perugia Italy
Author ProfileAlessandro D’Arpino
Hospital Pharmacy Unit Santa Maria della Misericordia Hospital Azienda Ospedaliera di Perugia Italy
Author ProfileMarta Tramontana
Section of Dermatology Department of Medicine and Surgery University of Perugia Italy
Author ProfileLuca Stingeni
Section of Dermatology Department of Medicine and Surgery University of Perugia Italy
Author Profile
